Markets:

Overview

News

Currencies

International

Treasuries

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

29.96 -0.10 (-0.33%)

Streaming Delayed Price Updated: 11:38 AM EST, Dec 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited American Depositary Shares

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

31 32 Next >

Benzinga's Top Ratings Upgrades, Downgrades For April 5, 2022 ↗

April 05, 2022

Upgrades

Via Benzinga

Why Are Teva Pharmaceutical Shares Trading Higher Today? ↗

February 09, 2022

Teva Pharmaceutical Industries Ltd's (NYSE: TEVA)

Via Benzinga

The Struggles Continue For Generic Drugs Behemoth Teva Pharmaceutical ↗

February 09, 2022

Teva reported light fourth-quarter sales as its own generic drugs struggled and Copaxone sales tumbled.

Via Investor's Business Daily

Teva to Host Conference Call to Discuss First Quarter 2022 Financial Results at 8 a.m. ET on May 3, 2022

April 04, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

West Virginia Says J&J, Teva, AbbVie Caused 'Tsunami' Of Opioid Addiction: Reuters ↗

April 04, 2022

West Virginia's attorney general urged a judge to hold Johnson & Johnson (NYSE: JNJ), Teva Pharmaceuticals Industries Ltd (NYSE: TEVA), and AbbVie Inc's (NYSE:

Via Benzinga

Teva to Present New Analyses of AJOVY® (fremanezumab-vfrm) Injection and AUSTEDO® (deutetrabenazine) Tablets at 2022 American Academy of Neurology Annual Meeting

April 01, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

CVS Health, Teva Settle Florida State's Opioid-Related Claims: Report ↗

March 30, 2022

Florida has reached more than $878 million in settlements with CVS Health Corp (NYSE: CVS) and three drug companies to resolve claims and avert a trial next month over their roles in fueling an opioid...

Via Benzinga

Teva Reaches Agreement With Florida to Settle the State’s Opioid-Related Claims

March 30, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

Monday Markets News ↗

March 28, 2022

Japanese Takeda TAK shares failed to thrive after its edema prevention drug was approved.

Via Talk Markets

Friday Markets News ↗

March 25, 2022

Methane leaks in the Permian Basin are 6 times higher than estimates.

Via Talk Markets

Rhode Island Announces $107M Opioid Settlements With Teva, Allergan: Reuters ↗

March 22, 2022

Rhode Island's attorney general announced settlements worth $107 million against Teva Pharmaceutical Industries Ltd (NYSE: TEVA) and AbbVie Inc's (NYSE: ABBV) Allergan unit to resolve claims over

Via Benzinga

Lucky Day ↗

March 21, 2022

Today Alleghany rose nearly 25% because it is being bought by Berkshire Hathaway, Warren Buffett's fund.

Via Talk Markets

Teva Reaches Agreement With Rhode Island to Settle Opioid-Related Claims

March 21, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

35 Generic Drugmakers Sign To Manufacture Low-Cost Version Of Pfizer's COVID Pill ↗

March 17, 2022

Via Benzinga

Hopes For A Peace Accord ↗

March 14, 2022

The winner today was BioNTech up 14.89% on hopes for new sales for the Covid-19 variant.

Via Talk Markets

Rhode Island's Opioid Trial Against Teva Begins Today: Reuters ↗

March 14, 2022

The first trial in Rhode Island state court against Teva Pharmaceutical Industries Ltd's (NYSE: TEVA) alleged responsibility for the opioid crisis begins jury...

Via Benzinga

7 Drug Stocks to Consider After the Viatris Plunge ↗

March 10, 2022

As Viatris and other generic drug makers plunge, what should you buy instead? Consider these seven well-known drug stocks, all of which are good value in what's still a pricey market.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Friday ↗

March 04, 2022

On Friday, 368 stocks hit new 52-week lows. Interesting Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...

Via Benzinga

Viatris To Pay $264M As EpiPen Antitrust Litigation Settlement: Reuters ↗

February 28, 2022

Viatris Inc (NASDAQ: VTRS), previously known as Mylan, has agreed to pay $264 million to resolve a class-action lawsuit alleging it engaged in a scheme to delay...

Via Benzinga

Putin on the brink ↗

February 28, 2022

For the first time in history, Swiss banks have penalized account owners for political actions and joined a SWIFT boycott.

Via Talk Markets

Red Ink ↗

February 24, 2022

There is little joy in stocks today as even companies reporting good results are being hit by fear of Ukraine sanctions.tbph

Via Talk Markets

A Receding tide ↗

February 23, 2022

Sanofi and GlaxoSmithKline have developed a new Covid-19 vaccine which they claim is 100% efficient.

Via Talk Markets

Psychedelic Drugs Market Growing as Prevalence of Mental Health Issues are Increasing Globally

February 24, 2022

Palm Beach, FL –– February 24, 2022 – FinancialNewsMedia.com News Commentary – The prevalence of mental health disorders has risen exponentially but the development of novel medications has not kept...

Via FinancialNewsMedia

World Markets News For Thursday ↗

February 17, 2022

Ericsson stock lost another 5.27% today in US markets.

Via Talk Markets

Global Cannabis Extract Market To Surpass $38B By 2030, Key Players Include Tilray, Canopy Growth, Aurora ↗

February 17, 2022

According to Coherent Market Insights, the global cannabis extract market is estimated to be valu...

Via Benzinga

Israeli Study Reveals Promising Medical Cannabis Results, Especially For PTSD Treatment ↗

February 16, 2022

A recent clinical trial conducted by Soroka University Medical Center and Israeli medical cannabis company Cannbit-Tikun O...

Via Benzinga

World Markets News For Monday ↗

February 14, 2022

European markets were down over fear of Ukrainian battles.

Via Talk Markets

Nuclear Winter ↗

February 11, 2022

Mexico is raising interest rates to 6%, from 5.5%.

Via Talk Markets

Inflation inflating ↗

February 10, 2022

The Fed will be raising interest rates soon and this will chop the appeal of investments in more vulnerable yield plays.

Via Talk Markets

Dampening Exuberance ↗

February 09, 2022

The bond sell-off halted today but the Fed's plans mean this will resume.

Via Talk Markets

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

31 32 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.